CoChat
Sign Up
Cited by 49

miR-195 inhibits macrophages pro-inflammatory profile and impacts the crosstalk with smooth muscle cells

Bras, Joao Paulo, Silva, Andreia Machado, Calin, George A., Barbosa, Mario Adolfo, Santos, Susana Gomes, Almeida, Maria Ines·2017·PLOS ONE
DOI 10.1371/journal.pone.0188530PMC PMC5699821
Open this paper in CoChat — free account

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0188530

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 42

  1. [1]Willerson JT, Ridker PM. Inflammation as a cardiovascular risk factor. Circulation. 2004; 109(21 Suppl 1): II2– I10. doi: 10.1161/01.CIR.0000129535.04194.38 15173056 · DOI · Paper page
  2. [2]Libby P. Inflammation in atherosclerosis. Arterioscler Thromb Vasc Biol. 2012; 32(9): 2045– 51. doi: 10.1161/ATVBAHA.108.179705 22895665 PMC3422754 · DOI
  3. [4]Tabas I, Bornfeldt KE. Macrophage phenotype and function in different stages of atherosclerosis. Circ Res. 2016; 118(4): 653– 67. doi: 10.1161/CIRCRESAHA.115.306256 26892964 PMC4762068 · DOI · Paper page
  4. [5]Randolph GJ. Mechanisms that regulate macrophage burden in atherosclerosis. Circ Res. 2014; 114(11): 1757– 71. doi: 10.1161/CIRCRESAHA.114.301174 24855200 PMC4059102 · DOI
  5. [6]Chinetti-Gbaguidi G, Colin S, Staels B. Macrophage subsets in atherosclerosis. Nat Rev Cardiol. 2014; 12(1): 10– 7. doi: 10.1038/nrcardio.2014.173 25367649 · DOI
  6. [7]Colin S, Chinetti-Gbaguidi G, Staels B. Macrophage phenotypes in atherosclerosis. ImmunolRev. 2014; 262(1): 153– 66. 25319333
  7. [8]Stöger JL, Gijbels MJJ, van der Velden S, Manca M, van der Loos CM, Biessen E a. L, et al Distribution of macrophage polarization markers in human atherosclerosis. Atherosclerosis. 2012; 225(2): 461– 8. doi: 10.1016/j.atherosclerosis.2012.09.013 23078881 · DOI
  8. [9]Leitinger N, Schulman IG. Phenotypic polarization of macrophages in atherosclerosis. Arterioscler Thromb Vasc Biol. 2013; 33(6): 1120– 6. doi: 10.1161/ATVBAHA.112.300173 23640492 PMC3745999 · DOI
  9. [10]Moore KJ, Sheedy FJ, Fisher E a. Macrophages in atherosclerosis: a dynamic balance. Nat Rev Immunol. 2013; 13(10): 709– 21. doi: 10.1038/nri3520 23995626 PMC4357520 · DOI · Paper page
  10. [11]Koga J, Aikawa M. Crosstalk between macrophages and smooth muscle cells in atherosclerotic vascular diseases. Vascul Pharmacol. 2012; 57(1): 24– 8. doi: 10.1016/j.vph.2012.02.011 22402259 · DOI
  11. [12]Almeida MI, Reis RM, Calin GA. MicroRNA history: Discovery, recent applications, and next frontiers. Mutat Res. 2011; 717(1–2): 1– 8. doi: 10.1016/j.mrfmmm.2011.03.009 21458467 · DOI · Paper page
  12. [13]Thulin P, Wei T, Werngren O, Cheung L, Fisher RM, Grandér D, et al MicroRNA-9 regulates the expression of peroxisome proliferator-activated receptor δ in human monocytes during the inflammatory response. Int J Mol Med. 2013; 31(5): 1003– 10. 23525285 PMC3658603
  13. [14]Ying H, Kang Y, Zhang H, Zhao D. MiR-127 modulates macrophage polarization and promotes lung inflammation and injury by activating the JNK pathway. J Immunol. 2015; 194(3): 1239– 51. doi: 10.4049/jimmunol.1402088 25520401 · DOI
  14. [15]O’Connell RM, Taganov KD, Boldin MP, Cheng G, Baltimore D. MicroRNA-155 is induced during the macrophage inflammatory response. Proc Natl Acad Sci U S A. 2007; 104(5): 1604– 9. doi: 10.1073/pnas.0610731104 17242365 PMC1780072 · DOI · Paper page
  15. [17]Taganov KD, Boldin MP, Chang K-J, Baltimore D. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci U S A. 2006; 103(33): 12481– 6. doi: 10.1073/pnas.0605298103 16885212 PMC1567904 · DOI · Paper page
  16. [19]Wang Y-S, Wang H-YJ, Liao Y-C, Tsai P-C, Chen K-C, Cheng H-Y, et al MicroRNA-195 regulates vascular smooth muscle cell phenotypes and prevents neointimal formation. Cardiovasc Res. 2012; 95(4): 517– 26. doi: 10.1093/cvr/cvs223 22802111 · DOI
  17. [20]Oliveira MI, Santos SG, Oliveira MJ, Torres AL, Barbosa MA. Chitosan drives anti-inflammatory macrophage polarisation and pro-inflammatory dendritic cell stimulation. Eur Cells Mater. 2012; 24: 136– 53. 22828991
  18. [21]Tsuchiya S, Yamabe M, Yamaguchi Y, Kobayashi Y, Konno T, Tada K. Establishment and characterization of a human acute monocytic leukemia cell line (THP-1). Int J Cancer. 1980; 26(2): 171– 6. 6970727
  19. [23]Almeida MI, Silva AM, Vasconcelos DM, Almeida CR, Caires H, Pinto MT, et al miR-195 in human primary mesenchymal stromal/stem cells regulates proliferation, osteogenesis and paracrine effect on angiogenesis. Oncotarget. 2016; 7(1): 7– 22. doi: 10.18632/oncotarget.6589 26683705 PMC4807979 · DOI
  20. [24]Chávez-Sánchez L, Garza-Reyes MG, Espinosa-Luna JE, Chávez-Rueda K, Legorreta-Haquet MV, Blanco-Favela F. The role of TLR2, TLR4 and CD36 in macrophage activation and foam cell formation in response to oxLDL in humans. Hum Immunol. 2014; 75(4): 322– 9. doi: 10.1016/j.humimm.2014.01.012 24486576 · DOI
  21. [25]Seneviratne AN, Sivagurunathan B, Monaco C. Toll-like receptors and macrophage activation in atherosclerosis. Clin Chim Acta. 2012; 413(1–2): 3– 14. doi: 10.1016/j.cca.2011.08.021 21884686 · DOI
  22. [26]Cole JE, Kassiteridi C, Monaco C. Toll-like receptors in atherosclerosis: A “Pandora”s box’ of advances and controversies. Trends Pharmacol Sci. 2013; 34(11): 629– 36. doi: 10.1016/j.tips.2013.09.008 24139612 · DOI
  23. [27]Oliveira MI, Pinto ML, Gonçalves RM, Martins MCL, Santos SG, Barbosa M a. Adsorbed Fibrinogen stimulates TLR-4 on monocytes and induces BMP-2 expression. Acta Biomater. 2017; 49: 296– 305. doi: 10.1016/j.actbio.2016.11.034 27856281 · DOI
  24. [28]Bosisio D, Polentarutti N, Sironi M, Bernasconi S, Miyake K, Webb GR, et al Stimulation of toll-like receptor 4 expression in human mononuclear phagocytes by interferon-gamma: a molecular basis for priming and synergism with bacterial lipopolysaccharide. Blood. 2002; 99(9): 3427– 31. 11964313
  25. [29]Zanoni I, Ostuni R, Marek LR, Barresi S, Barbalat R, Barton GM, et al CD14 controls the LPS-induced endocytosis of Toll-like Receptor 4. Cell. 2011; 147(4): 868– 80. doi: 10.1016/j.cell.2011.09.051 22078883 PMC3217211 · DOI · Paper page
  26. [30]Burdon KP, Rudock ME, Lehtinen AB, Langefeld CD, Bowden DW, Register TC, et al Human lipoxygenase pathway gene variation and association with markers of subclinical atherosclerosis in the diabetes heart study. Mediators Inflamm. 2010; 2010:Article ID 170153, 9 pages. PMC2878676 20592751
  27. [31]Averill MM, Kerkhoff C, Bornfeldt KE. S100A8 and S100A9 in cardiovascular biology and disease. Arterioscler Thromb Vasc Biol. 2012; 32(2): 223– 9. doi: 10.1161/ATVBAHA.111.236927 22095980 PMC3262097 · DOI
  28. [32]Gomez D, Owens GK. Smooth muscle cell phenotypic switching in atherosclerosis. Cardiovasc Res. 2012; 95(2): 156– 64. doi: 10.1093/cvr/cvs115 22406749 PMC3388816 · DOI
  29. [33]Mazza G, Robmanith E, Lang-Olip I, Pfeiffer D. Marker profile for the evaluation of human umbilical artery smooth muscle cell quality obtained by different isolation and culture methods. Cytotechnology. 2014; 68(4): 701– 11. doi: 10.1007/s10616-014-9822-0 25535117 PMC4960121 · DOI
  30. [34]Wang K, Sun Y, Tao W, Fei X, Chang C. Androgen receptor (AR) promotes clear cell renal cell carcinoma (ccRCC) migration and invasion via altering the circHIAT1/miR-195-5p/29a-3p/29c-3p/CDC42 signals. Cancer Lett. 2017; 394: 1– 12. doi: 10.1016/j.canlet.2016.12.036 28089832 · DOI
  31. [35]Qu Q, Chu X, Wang P. MicroRNA-195-5p suppresses osteosarcoma cell proliferation and invasion by suppressing naked cuticle homolog 1. Cell Biol Int. 2017; 41(3): 287– 95. doi: 10.1002/cbin.10723 28032380 · DOI
  32. [37]Chen T, Huang Z, Wang L, Wang Y, Wu F, Meng S, et al MicroRNA-125a-5p partly regulates the inflammatory response, lipid uptake, and ORP9 expression in oxLDL-stimulated monocyte/macrophages. Cardiovasc Res. 2009; 83(1): 131– 9. doi: 10.1093/cvr/cvp121 19377067 · DOI
  33. [39]Shoenfelt J, Mitkus RJ, Zeisler R, Spatz RO, Powell J, Fenton MJ, et al Involvement of TLR2 and TLR4 in inflammatory immune responses induced by fine and coarse ambient air particulate matter. J Leukoc Biol. 2009; 86(2): 303– 12. doi: 10.1189/jlb.1008587 19406832 PMC2726765 · DOI
  34. [40]Wang Q, Dziarski R, Kirschning CJ. Micrococci and Peptidoglycan Activate TLR2 -> MyD88 -> IRAK -> TRAF -> NIK -> IKK -> NF-kB Signal Transduction Pathway That Induces Transcription of Transcription of Interleukin-8. Infect Immun. 2001; 69(4): 2– 9. PMC98155 11254583
  35. [41]Matsuguchi T, Musikacharoen T, Ogawa T, Yoshikai Y. Gene expressions of Toll-like receptor 2, but not Toll-like receptor 4, is induced by LPS and inflammatory cytokines in mouse macrophages. J Immunol. 2000; 165(10): 5767– 72. 11067935
  36. [42]Liu Y, Wang Y, Yamakuchi M, Nagata E, Kanmura Y, Kitajima I. Upregulation of Toll-Like Receptor 2 Gene Expression in Macrophage Response to Peptidoglycan and High Concentration of Lipopolysaccharide Is Involved in NF- κ B Activation. Infect Immun. 2001; 69(5): 2788– 96. doi: 10.1128/IAI.69.5.2788-2796.2001 11292690 PMC98226 · DOI
  37. [43]Mullick AE, Tobias PS, Curtiss LK. Modulation of atherosclerosis in mice by Toll-like receptor 2. J Clin Invest. 2005; 115(11): 3149– 56. doi: 10.1172/JCI25482 16211093 PMC1242192 · DOI · Paper page
  38. [44]Philippe L, Alsaleh G, Suffert G, Meyer a, Georgel P, Sibilia J, et al TLR2 expression is regulated by microRNA miR-19 in rheumatoid fibroblast-like synoviocytes. J Immunol. 2012; 188(1): 454– 61. doi: 10.4049/jimmunol.1102348 22105995 · DOI
  39. [45]Benakanakere MR, Li Q, Eskan M a., Singh A V., Zhao J, Galicia JC, et al Modulation of TLR2 protein expression by miR-105 in human oral keratinocytes. J Biol Chem. 2009; 284(34): 23107– 15. doi: 10.1074/jbc.M109.013862 19509287 PMC2755716 · DOI
  40. [46]Fernández-Velasco M, González-Ramos S, Boscá L. Involvement of monocytes/macrophages as key factors in the development and progression of cardiovascular diseases. Biochem J. 2014; 458(2): 187– 93. doi: 10.1042/BJ20131501 24524191 · DOI · Paper page
  41. [48]Maiolino G, Rossitto G, Caielli P, Bisogni V, Rossi GP, Calo L a. The role of oxidized low-density lipoproteins in atherosclerosis: the myths and the facts. Mediators Inflamm. 2013; 2013:Article ID 714653, 13 pages. PMC3816061 24222937
  42. [49]Islam K, Timraz SBH, Nasser R, Gater DL, Pearson YE, Christoforou N, et al Co-culture Methods Used to Model Atherosclerosis In Vitro Using Endothelial, Smooth Muscle and Monocyte Cells. SM J Biomed Eng. 2016; 2(1): 1008.

Cited by

Sorted by citations

Authors
Bras, J. P., Silva, A. M., Calin, G. A., Barbosa, M. A., Santos, S. G., & Almeida, M. I.
Venue
PLOS ONE
Publisher
Public Library of Science (PLoS)
Published
2017-11-22
Volume
12
Issue
11
Pages
e0188530
ISSN
1932-6203
DOI
10.1371/journal.pone.0188530
PMC
PMC5699821
Cited by
49
References
6
Language
en
Licence
creativecommons.org/licenses/by/4.0/ (vor)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review